Location History:
- Linebeek, BE (2005)
- Linkebeek, BE (2002 - 2007)
- Brusselsl, BE (2008)
- Beersel, BE (2007 - 2010)
- Brussels, BE (2001 - 2011)
- Beerzel, BE (2010 - 2011)
Company Filing History:
23 out of 33 
1 out of 11 
2 out of 832,843 Years Active: 2001-2011
Title: The Innovative Contributions of Marc Parmentier
Introduction
Marc Parmentier, a notable inventor based in Beersel, Belgium, has made significant contributions to the field of biotechnology. With a remarkable portfolio of 26 patents, his work primarily focuses on the development of novel ligands and screening methods related to G-protein coupled receptors, which play a crucial role in various biological processes.
Latest Patents
Among Parmentier's most recent innovations are two pivotal patents:
1. **Methods of making an antibody that binds a chemerin polypeptide**: This invention delves into the realm of G-protein coupled receptors, providing valuable screening assays that aid in the identification of compounds capable of modulating receptor activity. The implications of this patent extend to diagnosing and treating diseases associated with receptor signaling dysregulation.
2. **Nucleic acids encoding ChemerinR ligands**: Similar to his first patent, this invention also addresses G-protein coupled receptors and introduces a novel ligand. It underscores the importance of identifying candidate compounds that can influence receptor activity, enhancing the potential for therapeutic interventions in related disorders.
Career Highlights
Throughout his career, Marc Parmentier has been associated with esteemed companies, notably Euroscreen S.A., where he has further refined his expertise in biotechnological innovations. His relentless pursuit of scientific advancement has led to numerous breakthroughs that contribute to the understanding and manipulation of cellular signaling.
Collaborations
In his journey as an inventor, Parmentier has collaborated with notable colleagues, including Gilbert Vassart and Michel Detheux. These partnerships have fostered an environment of shared knowledge and innovation, amplifying the impact of their collective research on the field.
Conclusion
Marc Parmentier exemplifies the spirit of innovation within the biotechnology sector. His extensive patent portfolio not only showcases his ingenuity but also his commitment to advancing medical science through the understanding of receptor signaling. As he continues to contribute to this critical area of research, Parmentier's work holds great promise for future therapeutic advancements.